ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

Modern Pathology, Published online: 16 July 2022; doi:10.1038/s41379-022-01130-7ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

Source: Modern Pathology - July 16, 2022 Category: Pathology Authors: Isabel Grote Stephan Bartels Henriette Christgen Martin Radner Malte Gronewold Leonie Kandt Mieke Raap Ulrich Lehmann Oleg Gluz Monika Graeser Sherko Kuemmel Ulrike Nitz Nadia Harbeck Hans Kreipe Matthias Christgen Source Type: research